ID   HeLa TG
AC   CVCL_2935
SY   HeLaTG
DR   CLO; CLO_0050922
DR   JCRB; JCRB0214
DR   RCB; RCB1891
DR   TKG; TKG 0204
DR   Wikidata; Q54882683
RX   PubMed=1522048;
RX   PubMed=9290701;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB0214; RCB=RCB1891; TKG=TKG 0204
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
RX   PubMed=1522048; DOI=10.1007/BF02634140;
RA   Kataoka E., Honma M., Ohnishi K., Sofuni T., Mizusawa H.;
RT   "Application of highly polymorphic DNA markers to the identification
RT   of HeLa cell sublines.";
RL   In Vitro Cell. Dev. Biol. Anim. 28:553-556(1992).
//
RX   PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D;
RA   Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T.,
RA   Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M.,
RA   Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.;
RT   "Screening the p53 status of human cell lines using a yeast functional
RT   assay.";
RL   Mol. Carcinog. 19:243-253(1997).
//